RENAGEL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug RENAGEL contains one active pharmaceutical ingredient (API):

1 Sevelamer UNII GLS2PGI8QG - SEVELAMER HYDROCHLORIDE

Sevelamer is a non-absorbed phosphate binding crosslinked polymer, free of metal and calcium. Sevelamer contains multiple amines separated by one carbon from the polymer backbone which become protonated in the stomach. These protonated amines bind negatively charged ions such as dietary phosphate in the intestine. Read about Sevelamer

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE02	Sevelamer	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2142R, 9546K, 9620H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720090086717
Country: CA	Health Products and Food Branch	Identifier(s): 02244310
Country: EE	Ravimiamet	Identifier(s): 1123063, 1123074, 1215155, 1215166, 1215177, 1215188, 1215199
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99123012
Country: FR	Base de données publique des médicaments	Identifier(s): 68950692
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 182909, 368722, 375941, 381658
Country: HK	Department of Health Drug Office	Identifier(s): 52216
Country: IT	Agenzia del Farmaco	Identifier(s): 034676080
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190025F1036
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030653, 1030654, 1030655, 1030656, 1030657, 1030658, 1030659, 1030660, 1050549
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 001M2007
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 60496
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11629
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100111334, 100111340
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08985002
Country: US	FDA, National Drug Code	Identifier(s): 58468-0021